Wole Akosile

Dr. Wole Akosile

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2018 in Australasian Psychiatry
Verified
Journal Article
Closed access
WAWole Akosile
Wole Akosile
DCDavid Colquhoun
David Colquhoun
RYRoss Young
Ross Young
BLBruce Lawford
Bruce Lawford
JVJoanne Voisey
Joanne Voisey
There are some psychosocial factors that have similar importance to biological factors in the genesis of coronary diseases. However, reasons for high rates of coronary heart disease in individuals with post-traumatic stress disorder (PTSD) are yet to be fully elucidated. Using a meta-analysis, we investigated the longitudinal relationship between PTSD and coronary heart disease (CHD) as an independent factor in the aetiology of CHD. The databases of Medline, EBSCOhost and Psychoinfo were electronically searched for relevant articles. The pooled hazard ratio (HR) for the magnitude of the relationship between PTSD and CHD was an HR of 1.61, and p-value of p < 0.0005, 95% confidence interval (CI) [1.46–1.77] before adjustment for depression in nine studies (N = 151,144) that met inclusion criteria. The HR estimates for the seven depression-adjusted estimates was 1.46, and a p-value of p < 0.0005, 95% CI[0.26–1.69]. This study demonstrates an association between CHD and PTSD.

28 February 2023 in Asian Journal of Psychiatry
Verified
Journal Article
Open access
WAWole Akosile
Wole Akosile
BTBabangida Tiyatiye
Babangida Tiyatiye
DCDavid Colquhoun
David Colquhoun
RYRoss Young
Ross Young
Depression is an independent risk factor for coronary artery disease (CAD). Both illnesses contribute significantly to the global burden of disease. This systematic literature review examines treatment interventions for CAD patients with comorbid depression. We systematically reviewed The Cochrane Library, MEDLINE, EMBASE, PsycINFO, PUBMED, CINAHL and the ISRCTN Registry for English language randomised control trials investigating treatment interventions for depression in adults with CAD and comorbid depression. Data extracted included author name(s), year published, number of participants, enrolment criteria, depression definition/measures (standardised interviews, rating scales), description of control arms and interventions (psychotherapy and/or medications), randomisation, blinding, follow-up duration, follow-up loss, depression scores and medical outcome. The database search revealed 4464 articles. The review yielded 19 trials. Antidepressant and/or psychotherapy did not significantly influence CAD outcomes in the overall population. There was no difference between antidepressant use and aerobic exercises. Psychological interventions and pharmacological interventions provide small effect on depression outcomes in CAD patients. Patient autonomy in choice of treatment is associated with greater depression treatment satisfaction, but the majority of studies are underpowered. More research is required to explore the role of neurostimulation treatment, complementary and alternative treatments.

1 December 2018 in Psychiatry Research
Verified
Journal Article
Closed access
WAWole Akosile
Wole Akosile
JVJoanne Voisey
Joanne Voisey
BLBruce Lawford
Bruce Lawford
DCDavid Colquhounc
David Colquhounc
RYRoss McD Young
Ross McD Young
DMDivya Mehta
Divya Mehta

12 February 2015 in Australasian Psychiatry
Verified
Journal Article
Closed access
WAWole Akosile
Wole Akosile
BMBrett M McDermott
Brett M McDermott
Objective: This study investigates if the routine use of the urine drug screen offers any diagnostic or management benefit in the assessment and treatment of psychiatry patients in a suburban psychiatry emergency service. Methods: Data was collected retrospectively from consecutive patients 18 years and above, who presented to a large suburban hospital emergency department and had a urine drug screen ordered in the emergency department. A total of 111 patients, (with mean age of participants being 34.9 years, SD 10.2 years, minimum 18 – maximum 62 years, 62.2% (69/111) were male) met the inclusion criteria. Results: The most common drug group identified was benzodiazepines (59.5%; 66/111), followed by cannabis (40.5%; 45/111). Other drugs were identified at much lower levels, including amphetamines (9.0%; 10/111), opiates (4.5%; 5/111) and methadone (0%; 0/111). For most individuals only one drug was detected (55.9%; 62/111), with equal numbers (18.9%) with either zero or two drugs identified by a urine drug screen. Fewer patients had three drugs on a urine drug screen (5.4%; 6/111) or four (0.9%; 1/111). Conclusions: Qualitative urine drug screens provide limited additional information compared to history taking and has minimal impact on clinical management decisions in a psychiatry emergency service.

1 January 2020 in Gene
Verified
Journal Article
Closed access
WAWole Akosile
Wole Akosile
JVJoanne Voisey
Joanne Voisey
BLBruce Lawford
Bruce Lawford
DCDavid Colquhoun
David Colquhoun
RYRoss McD Young
Ross McD Young
DMDivya Mehta
Divya Mehta

10 October 2017 in Australasian Psychiatry
Verified
Journal Article
Closed access
WAWole Akosile
Wole Akosile
RYRoss Young
Ross Young
BLBruce Lawford
Bruce Lawford
JVJoanne Voisey
Joanne Voisey
DCDavid Colquhoun
David Colquhoun
Several studies have demonstrated a link between post-traumatic stress disorder and myocardial infarction. We aim to determine what phenotypic features or symptom profile associated with cardiovascular disease may help with early detection and intervention. This is a cross-sectional study. The study population comprises trauma-exposed Vietnam War veterans. Variables significantly associated with myocardial infarction from the bivariate analysis were avoidance memories, avoidance reminders and sleep disturbance. These variables were put into a logistic regression with known risk factors for myocardial infarction. Only sleep disturbance retained its effect, with a p-value of 0.015. It is concluded that sleep disturbance may be a modifiable risk factor in the treatment and prevention of myocardial infarction.